Dow Up 0.12% Nasdaq Up 1.35%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
1.50 0.06(4.17%) Oct 20, 4:00PM EDT
Prev Close:1.44
Open:1.41
Bid:N/A
Ask:1.69 x 5000
1y Target Est:1.96
Beta:2.57
Next Earnings Date:N/A
Day's Range:1.40 - 1.52
52wk Range:1.00 - 8.46
Volume:2,287,633
Avg Vol (3m):2,057,400
Market Cap:90.66M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSSUp 4.17%90.66M
AZN85.82B
PFE177.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback